Zhejiang Dayang Biotech Group Co., Ltd. (003017) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Zhejiang Dayang Biotech Group Co., Ltd.

Why is Zhejiang Dayang Biotech Group Co., Ltd. ?

Positive results in Mar 25

RAW MATERIAL COST(Y) Fallen by -35.93% (YoY)
NET SALES(Q) Highest at CNY 247.17 MM
PRE-TAX PROFIT(Q) Highest at CNY 31.31 MM

With ROE of 7.52%, it has a very attractive valuation with a 2.03 Price to Book Value

Over the past year, while the stock has generated a return of 66.77%, its profits have risen by 39.7% ; the PEG ratio of the company is 0.7
At the current price, the company has a high dividend yield of 0.9

Market Beating Performance

The stock has generated a return of 66.77% in the last 1 year, much higher than market (China Shanghai Composite) returns of 15.18%

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to Zhejiang Dayang Biotech Group Co., Ltd. should be less than 10%
Overall Portfolio exposure to Chemicals & Petrochemicals should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Chemicals & Petrochemicals)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Zhejiang Dayang Biotech Group Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Zhejiang Dayang Biotech Group Co., Ltd.

39.45%

2.14

44.26%

China Shanghai Composite

14.77%

1.01

15.10%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

6.90%

EBIT Growth (5y)

-1.40%

EBIT to Interest (avg)

10.37

Debt to EBITDA (avg)

0.12

Net Debt to Equity (avg)

0.04

Sales to Capital Employed (avg)

0.67

Tax Ratio

10.04%

Dividend Payout Ratio

39.06%

Pledged Shares

Institutional Holding

ROCE (avg)

5.61%

ROE (avg)

7.03%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.03

EV to EBIT

29.94

EV to EBITDA

15.68

EV to Capital Employed

2.05

EV to Sales

2.27

PEG Ratio

0.68

Dividend Yield

0.92%

ROCE (Latest)

6.85%

ROE (Latest)

7.52%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bearish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

16What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -35.93% (YoY

NET SALES(Q)

Highest at CNY 247.17 MM

PRE-TAX PROFIT(Q)

Highest at CNY 31.31 MM

NET PROFIT(Q)

Highest at CNY 29.7 MM

EPS(Q)

Highest at CNY 0.35

-5What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 110.19 MM

DEBT-EQUITY RATIO (HY)

Highest at 4.15 %

OPERATING PROFIT(Q)

Lowest at CNY 24.26 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 9.82 %

Here's what is working for Zhejiang Dayang Biotech Group Co., Ltd.

Net Sales

Highest at CNY 247.17 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Net Sales

At CNY 247.17 MM has Grown at 27.76%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Pre-Tax Profit

Highest at CNY 31.31 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Pre-Tax Profit

At CNY 31.31 MM has Grown at 75.05%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 29.7 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Net Profit

At CNY 29.7 MM has Grown at 75.52%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.35

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Raw Material Cost

Fallen by -35.93% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Zhejiang Dayang Biotech Group Co., Ltd.

Operating Cash Flow

Lowest at CNY 110.19 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Operating Profit

Lowest at CNY 24.26 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 9.82 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Debt-Equity Ratio

Highest at 4.15 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio